摘要
恶性肿瘤患者较普通人群更易发生静脉血栓栓塞(venous thromboembolism),且静脉血栓栓塞是仅次于恶性肿瘤原发病本身的恶性肿瘤患者的第2大死亡原因。肺癌(lung cancer)是静脉血栓发生风险较高的恶性肿瘤之一。在静脉血栓栓塞中,又以肺栓塞(pulmonary embolism)较为凶险,对肺癌患者的治疗、病情及预后有着重要影响。该文主要就肺癌患者发生肺栓塞的机制、危险因素及目前的预测模型进行阐述。
Cancer patients are more likely to develop venous thromboembolism than the general population,and venous thromboembolism is the second leading cause of death in cancer patients after the primary cause of cancer itself.Lung cancer is one of the cancer types with the highest risk of venous thrombosis.Among venous thromboembolism,pulmonary embolism is the most dangerous and has a significant impact on the treatment,condition and prognosis of lung cancer patients.This paper discussed the pathogenesis,risk factors and current predictive models of pulmonary embolism in patients with lung cancer.
作者
王东梅
韩锋锋
WANG Dongmei;HAN Fengfeng(Department of Respiratory,Xinhua Hospital Affiliated to Jiao Tong University School of Medicine,Shanghai 200092,China)
出处
《世界临床药物》
CAS
2024年第3期239-243,共5页
World Clinical Drug
关键词
肺癌
肺栓塞
发病机制
危险因素
临床预测模型
lung cancer
pulmonary embolism
pathogenesis
risk factor
clinical prediction model
